Mark Cuban walked into the Senate with spreadsheets and receipts. He called PBMs a cartel. He saved Medicare $2 billion. But math doesn't show up at town halls. Receipts don't vote. Here's the hole in his equation and an invitation to fix it.

Mark Cuban exposes PBM corruption and champions transparent drug pricing. He is right about generics. He is wrong about cash solving catastrophic care. A brain cancer survivor explains why $12 prescriptions and $960,000 transplants live in different universes.

In 2025, seven insurers generated $1.7 trillion in revenue and $54 billion in profit while covering 10 million fewer people. Premiums hit $26,993 for families. Public funding expanded. Consolidation deepened. The incentive structure driving American health insurance stands exposed.

UnitedHealth dropping Medicare Advantage plans for 600000 beneficiaries exposes a structural flaw in how private insurers manage public healthcare risk as costs from emergency care and specialty drugs accelerate faster than payment models can adjust.

A personal reflection on Gil Bashe’s Healing the Sick Care System and the growing revolt against insurance driven harm. From hospital memories to national accountability, this piece calls out who holds the wheel and why 2026 signals the rise of the patient voter bloc.

Blue Cross Blue Shield says insurers protect patients from high drug prices. The real world shows delays, denials, and blame shifting while patients wait, appeal, and deteriorate. A closer look at how insurers deflect responsibility in the drug pricing debate.

A new KFF poll shows prior authorization now ranks as the biggest burden in American healthcare. Delays and denials affect nearly half of insured adults, with severe mental, financial, and physical consequences. Patients across every plan agree.

Health insurers turned “medically necessary” into a denial weapon. This article breaks down how coverage policies, anonymous medical directors, and financial incentives allow insurers to override doctors and block cancer care, then outlines concrete fixes that could shut the system down.

After surviving brain cancer at 21, Matthew Zachary examines how modern healthcare policy repackages risk as freedom. From cash subsidies to math free promises, this essay exposes why consumer style healthcare fails the moment illness enters the room.

24 million Americans watched premiums double overnight. Now Trump plans to pressure insurers who banked $543 billion in profits over a decade. The solution? HSAs—which create new revenue streams for the same industry while shifting costs onto patients who already can't afford care. This isn't reform.

Congress left while ACA subsidies expired. Premiums spiked 114%. UnitedHealthcare dumped costly seniors. RFK Jr. gutted the CDC. NIH cancer research was slashed. The advocacy community stayed silent. 2025 was a catastrophe for patients. If you can't admit that, you're complicit. Be pissed.

Congress left for vacation knowing ACA subsidies would expire. In 2026 premiums spiked as high as 114 percent, millions face dropping coverage, and patients carry the cost. This is not partisan politics. This is survival, access, and who gets left behind.

People call it overnight success. From the inside it looks like decades of repetition endurance and saying uncomfortable truths out loud. This reflection examines advocacy patience family grounding and why progress in healthcare only comes through time memory and staying power.

Congress let ACA subsidies expire and premiums are set to more than double. Most ACA enrollees live in GOP districts now facing coverage loss hospital closures and higher costs for everyone. The healthcare death spiral has arrived and it targets its own voters first.

Prior authorization delays cancer care and drives preventable deaths. Oncologists report treatment denials disease progression and ER visits caused by insurer delays. What began as medical review now functions as weaponized paperwork that outlasts patients.